Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-79.55M
↓ 106% below average
Average (4y)
$-38.63M
Historical baseline
Range
High:$-5.29M
Low:$-79.55M
CAGR
+96.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-79.55M | -32.9% |
| 2023 | $-59.85M | -85.3% |
| 2022 | $-32.29M | -100.0% |
| 2021 | $-16.15M | -205.1% |
| 2020 | $-5.29M | - |